ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-131710 |   Others

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Entrusted R&D And Manufacturing Of New Investigational Drugs Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET

7.1 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA ENTRUSTED R&D AND MANUFACTURING OF NEW INVESTIGATIONAL DRUGS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Covance Inc

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Charles River Laboratories Inc

16.3 Cambrex Corporation

16.4 IQVIA Holdings Inc

16.5 Syneos Health

16.6 Lonza

16.7 Catalent

16.8 Recipharm AB

16.9 Siegfried Holding AG

16.10 Thermo Fisher Scientific Inc

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Entrusted R&D
OEM

By Application
pharmacy
Biotechnology
other

Companies

Covance Inc
Charles River Laboratories Inc
Cambrex Corporation
IQVIA Holdings Inc
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.